FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2–induced resistance
Bibliography
Westover, D., Ling, X., Lam, H., Welch, J., Jin, C., Gongora, C., ... Li, F. (2015). FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2–induced resistance. Molecular Cancer, 14(92), 1 - 11.